The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prescribing patterns for bevacizumab in first-line metastatic colorectal cancer: Exploring the introduction of a new drug into routine clinical practice.
Kathryn Maree Field
Research Funding - Roche
Jayesh Desai
Research Funding - Roche
Jeanne Tie
No relevant relationships to disclose
Suzanne Kosmider
No relevant relationships to disclose
Susie Bae
No relevant relationships to disclose
Joseph James McKendrick
No relevant relationships to disclose
Michael Harold
No relevant relationships to disclose
Peter Gibbs
Consultant or Advisory Role - Roche (U)
Research Funding - Roche